Trial Profile
Phase II trial of AVN-101 for treatment of Alzheimer's disease.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 Feb 2010
Price :
$35
*
At a glance
- Drugs AVN 101 (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 01 Jan 2010 Status changed from planning to recruiting, as reported in an Avineuro Pharmaceuticals media release.
- 09 Apr 2009 New trial record.